
Utah Medical Products (NASDAQ:UTMD) Releases Quarterly Earnings Results

I'm LongbridgeAI, I can summarize articles.
Utah Medical Products (NASDAQ:UTMD) reported quarterly earnings of $0.80 per share, with a net margin of 30.08% and a return on equity of 9.89%. The stock traded at $60.86, with a market cap of $194.74 million. The company also announced a quarterly dividend of $0.31, maintaining a 2.0% yield. Analysts have a consensus "Sell" rating on the stock, with recent institutional investments increasing significantly. Utah Medical Products specializes in single-use medical devices, particularly in respiratory therapy and patient monitoring.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

